9 October 2024
Welcoming New Editorial Board Members of Cancers
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are pleased to announce that five new scholars have been appointed as Editorial Board Members (EBMs) of Cancers (ISSN: 2072-6694) in 2024. We wish our new members success in both their research and the efforts to develop the journal.
Name: Dr. Miquel Taron
Affiliations: 1. Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), 41013 Sevilla, Spain; 2. Synlab Diagnosticos Globales SAU, 28108 Madrid, Spain
Interests: oncology; ERCC; soft tissue sarcoma
Name: Prof. Dr. R. Steven Conlan
Affiliation: Medical School, Swansea University, Singleton Park, Swansea SA2 8PP, UK
Interests: cancer drug discovery; epigenomics; nanomedicines; antibody drug conjugates; exosomes; pre-clinical models; AI; functional genomics; nanosensors
Name: Prof. Dr. Sebastiano Mercadante
Affiliation: Main Regional Center for Pain Relief & Palliative Care Unit, La Maddalena Cancer Center, Via San Lorenzo 312, 90146 Palermo, Italy
Interests: cancer pain; opioids; palliative care
Name: Dr. Takuji Tanak
Affiliation: Department of Diagnostic Pathology and Research Center of Diagnostic Pathology, Gifu Municipal Hospital, 7-1 Kashima-cho, Gifu 500-8513, Japan
Interests: colorectal carcinogenesis; cancer chemoprevention; inflammatory bowel disease; ulcerative colitis; Crohn’s disease; animal model
Name: Prof. Dr. Tomoharu Yoshizumi
Affiliation: Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka City 812-8582, Fukuoka, Japan
Interests: liver; transplantation; hepatocellular carcinoma; cholangiocellular carcinoma; surgery
Further details about the Editorial Board of Cancers can be found by clicking the following link: https://www.mdpi.com/journal/cancers/editors.
Cancers is recruiting scholars from around the world to join our Editorial Board. To apply for membership, recommend potential candidates, or request further information, please contact the Cancers Editorial Office (cancers@mdpi.com) and provide the following files: